ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,000 | +300.0% | 1,930 | +589.3% | 0.00% | – |
Q2 2023 | $1,000 | -80.0% | 280 | -85.3% | 0.00% | – |
Q1 2023 | $5,000 | -70.6% | 1,903 | -63.8% | 0.00% | – |
Q4 2022 | $17,000 | +70.0% | 5,257 | +48.5% | 0.00% | – |
Q3 2022 | $10,000 | +400.0% | 3,540 | +621.0% | 0.00% | – |
Q2 2022 | $2,000 | -98.6% | 491 | -95.4% | 0.00% | – |
Q1 2022 | $143,000 | -56.9% | 10,617 | -58.3% | 0.00% | – |
Q4 2021 | $332,000 | -65.1% | 25,462 | -74.9% | 0.00% | – |
Q3 2021 | $952,000 | -39.9% | 101,513 | -34.4% | 0.00% | – |
Q2 2021 | $1,585,000 | -34.7% | 154,739 | +17.2% | 0.00% | -100.0% |
Q1 2021 | $2,429,000 | -8.8% | 131,995 | +69.8% | 0.00% | 0.0% |
Q4 2020 | $2,663,000 | +424.2% | 77,747 | +182.7% | 0.00% | – |
Q3 2020 | $508,000 | – | 27,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
Logos Global Management LP | 220,000 | $671,000 | 0.12% |
PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
SG3 Management, LLC | 206,000 | $628,000 | 0.07% |